Inhibitor Therapeutics Inc.

Inhibitor Therapeutics Inc. financial statements

Inhibitor Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

Net income−USD 3.3M10-K
Cash and equivalentsUSD 2.38M10-Q
Total debtUSD 24.72K10-Q

Inhibitor Therapeutics Inc. financials on 6ix · Inhibitor Therapeutics Inc. on 6ix